CollPlant Biotechnologies Analyst Ratings
CollPlant Biotechnologies Analyst Ratings
While ratings are subjective and will change, the latest CollPlant Biotechnologies (CLGN) rating was a reiterated with a price target of $0.00 to $11.00. The current price CollPlant Biotechnologies (CLGN) is trading at is $6.69, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/25/2023 | 64.42% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 03/30/2023 | 64.42% | HC Wainwright & Co. | $26 → $11 | Maintains | Buy |
| 02/17/2023 | 240.06% | Alliance Global Partners | → $22.75 | Initiates Coverage On | → Buy |
| 02/09/2021 | 288.64% | HC Wainwright & Co. | $13 → $26 | Maintains | Buy |
| 05/28/2020 | 94.32% | HC Wainwright & Co. | $11 → $13 | Reiterates | → Buy |
| 04/03/2020 | 64.42% | HC Wainwright & Co. | $7 → $11 | Reiterates | → Buy |
| 12/18/2018 | 4.63% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/25/2023 | 64.42% | HC Wainwright & Co. | → 11 美元 | 重申 | 購買 → 購買 |
| 03/30/2023 | 64.42% | HC Wainwright & Co. | 26 美元 → 11 美元 | 維護 | 購買 |
| 02/17/2023 | 240.06% | 聯盟全球合作伙伴 | → 22.75 美元 | 啓動覆蓋開啓 | → 購買 |
| 02/09/2021 | 288.64% | HC Wainwright & Co. | 13 美元 → 26 美元 | 維護 | 購買 |
| 05/28/2020 | 94.32% | HC Wainwright & Co. | 11 美元 → 13 美元 | 重申 | → 購買 |
| 2020 年 3 月 4 日 | 64.42% | HC Wainwright & Co. | 7 美元 → 11 美元 | 重申 | → 購買 |
| 12/18/2018 | 4.63% | HC Wainwright & Co. | → 7 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for CollPlant Biotechnologies (CLGN)?
CollPlant Biotechnologies（CLGN）的目標價格是多少？
The latest price target for CollPlant Biotechnologies (NASDAQ: CLGN) was reported by HC Wainwright & Co. on August 25, 2023. The analyst firm set a price target for $11.00 expecting CLGN to rise to within 12 months (a possible 64.42% upside). 3 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月25日公佈了CollPlant Biotechnologies（納斯達克股票代碼：CLGN）的最新目標股價。該分析公司將目標股價定爲11.00美元，預計CLGN將在12個月內上漲至64.42％（可能上漲64.42％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for CollPlant Biotechnologies (CLGN)?
CollPlant Biotechnologies（CLGN）的最新分析師評級是多少？
The latest analyst rating for CollPlant Biotechnologies (NASDAQ: CLGN) was provided by HC Wainwright & Co., and CollPlant Biotechnologies reiterated their buy rating.
HC Wainwright & Co. 提供了CollPlant Biotechnologies（納斯達克股票代碼：CLGN）的最新分析師評級，CollPlant Biotechnologies重申了買入
When is the next analyst rating going to be posted or updated for CollPlant Biotechnologies (CLGN)?
CollPlant Biotechnologies（CLGN）的下一份分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CollPlant Biotechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CollPlant Biotechnologies was filed on August 25, 2023 so you should expect the next rating to be made available sometime around August 25, 2024.
分析師在進行了廣泛的研究後得出了股票評級，包括閱讀公開財務報表、與CollPlant Biotechnologies的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。CollPlant Biotechnologies的最新評級是在2023年8月25日提交的，因此你應該預計下一個評級將在2024年8月25日左右公佈。
Is the Analyst Rating CollPlant Biotechnologies (CLGN) correct?
分析師對CollPlant Biotechnologies（CLGN）的評
While ratings are subjective and will change, the latest CollPlant Biotechnologies (CLGN) rating was a reiterated with a price target of $0.00 to $11.00. The current price CollPlant Biotechnologies (CLGN) is trading at is $6.69, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但重申了最新的CollPlant Biotechnologies（CLGN）評級，目標股價爲0.00美元至11.00美元。CollPlant Biotechnologies（CLGN）目前的交易價格爲6.69美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。
